Study of bronchial spasm resolution after methacholine challenge. Comparison between patients with different hyperreactivity degree;Studio della risoluzione spontanea del broncospasmo dopo PD con metacolina. Confronto tra pazienti con iperreattivita di diverso grado

Recenti Progressi in Medicina

Volumn 88, Issue 3, 1997, Pages 115-119

  Mannino, Francesco ^a   Anticoli, Sabrina ^a   Graziani, Elda ^a   Terzano, Claudio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

hyperreactivity degree; methacholine challenge; recovery phase of bronchial spasm

Indexed keywords

METHACHOLINE;

ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE;

ADULT; ANALYSIS OF VARIANCE; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL SPASM; BRONCHOCONSTRICTOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; TIME FACTORS;

EID: 0030977420     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Orehek J, Gayrard P. Les tests de provocation bronchique non-spécifiques dans l'asthme. Bull Eur Physio-pathol Respir 1976; 12: 565-98.
2. Boushey HA, Holtzman MK, Sheller JR, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis 1980; 121: 389-413.
3. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-27.
4. Sterk PJ, Fabbri LM, Quanjer Ph H, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6, suppl. 16: 53-83.
5. Malmberg P, Larsson K, Sundblad BM, Zhiping W. Importance of time interval between FEV1 measurements in a methacholine provocation test. Eur Respir J 1993; 6: 680-6.
6. Pellegrino R, Vilante B, Brusasco B. Maximal bronchoconstriction in humans. Relationship to deep inhalation and airway sensitivity. Am J Respir Crit Care Med 1996; 153: 115-21.
7. Cartier A, Malo JL, Begin P, Sestier M, Martin RR. Time course of the bronchoconstriction induced by inhaled histamine and methacholine. J Appl Physiol 1983; 54(3): 821-6.
8. Andrè-Alves MR, Tse S, McClean PA, et al.: The time course of methacholine induced bronchoconstriction in asthmatic and healthy subjects. Am J Res Critical Care Medicine (abstract) 1994; 149S(4): 1049.
9. Magnussen H, Novwak D, Ziebicke W. Effect of inhaled ipratropium bromide on the airway response to methacholine, histamine and exercise in patients with mild bronchial asthma. Respiration 1992; 59: 42-7.
10. Sanna A, Kurtansky A, Veriter C, Stanescu D. Bronchodilator effect of inhaled nitric oxide in healthy men. Am J Respir Crit Care Med 1994; 150: 1702-4.
11. Wu SC, Hildebrandt J, Isner PD, Pierson DJ, Bishop MJ. Efficacy of anticholinergic and beta-adrenergic agonist. Treatment of maximal cholinergic bronchospasm in tracheally intubated rabbits. Anesth Analg 1992; 75: 777-83.
12. Mannino F, Anticoli S, De Luca A, Terzano C. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution. Allergol et Immunopathol 1996; 24(2): 70-4.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
14. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of a general population. Am Rev Respir Dis 1991; 143: 516-21.
15. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using technique and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123: 659-64.
16. Standardization of spirometry. Am Rev Respir Dis 1987; 136: 1285-9.
17. Balzano G, Schiano M, Cocco M, et al. Me.Far dosimeter in bronchial provocation testing with pharmacological agents. Respir News Bull 1984; 26: 3-5.
18. Balzano G, Delli Cari I, Gallo C, Cocco G, Melillo G. Intrasubject between day variability of PD20 methacholine assessed by the dosimeter inhalation test. Chest 1989; 95: 1239-43.